Nanostructured Drug Market Widespread Research and Fundamental study to 2026
Nanotechnology
is an emerging field of science that involves atomic or molecular
level manipulation of matter. A nanometer is equals to 1 billionth of
a meter. Nanotechnology has various application in different fields
such as chemical sensors, batteries, food, fuel cells, solar cells,
fabric, fuels, electronics, space, better air quality, cleaner water,
and sporting goods. One of the key application of nanotechnology is
in medicine, nano-medicine ranges from the medical application such
as biological device, nanomaterial, nanoelectronic biosensors, and
biological machines. Nanotechnology has presented the option of drug
delivery to specific target cells employing nanoparticles. Particles
are engineered to attach to diseases cells, which allows of direct
treatment of those cells. Drug delivery techniques are designed to
reduce the side effects associated with the drugs along with decrease
in its consumption and treatment costs. Nanostructured drugs have
various applications such as in neurology, cardiovascular/physiology,
anti-inflammatory/immunology, anti-infective, and others.
Nanostructured
Drug Market Dynamics
Nanostructured drugs
are gaining significant traction in research and development due to
the benefits offered by them in terms of bioavailability, drug
stability, shelf-life and dosage. Effective and safe drug delivery is
a major challenge in biotechnology and pharmaceutical manufacturers.
Novel techniques such as nanotechnology are being introduced by
companies to produce innovative product, which is driving growth of
the nanostructured drug market. For instance, in 2015, the Food and
Drug Administration (FDA) approved Onivyde, an irinotecan liposome
injection by merrimack pharmaceuticals, which is a prescription
medicine used to treat pancreatic cancer. Onivyde is administered in
combination with two other drugs, leucovorin and fluorouracil.
Onivyde consists of a chemotherapy drug called irinotecan, which
interrupts cell reproduction. Irinotecan is trapped into a
nanostructure called liposome. Liposomes are programmed to release
drug slowly within the interval of time.
Moreover, increased
funding and revenue from nano-enabled products have propelled growth
of nanostructured drug market. For instance, According to the
National Science Foundation 2014 market report, the global funding
for emerging nanotechnology increased by 40% to 45% for past three
years. Furthermore, worldwide revenue generated by nano-enabled
products have been increased from US$ 339 billion in 2010 to US$ 731
billion in 2012, and to more than US$1 trillion in 2013.
However, high cost
required for the development of nanostructured drugs and safety risks
associated with nanostructured drugs such as the duration of time
nanoparticles remain in the body, which affects cellular and tissue
functions is restraining the market growth.
Request For
Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1841
Nanostructured
Drug Market – Regional Insights
Based on the region,
the global nanostructured drug treatment market is segmented into
North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa. North America holds the dominant position in the global
nanostructured drug market, owing to massive funding by the
government for the nanotechnology research. For instance, According
to a study led by Lux Research with funding support from U.S.
national Foundation and U.S. National Nanotechnology Coordination
Office in 2013, around US$ 1.9 billion was funded in 2011 and US$ 2.1
billion in 2012 for nanotechnology research and development (R&D).
Moreover, increasing awareness among the population regarding various
chronic diseases and well established healthcare infrastructure is
expected to propel the nanostructured drug market growth over the
forecast period.
Asia pacific is
expected to gain significant market share in the nanostructured drug
market, followed by Europe, owing to increasing number of population
susceptible to various chronic diseases such cancer, HIV, and
tuberculosis. For instance, according to the National Health and
Family Planning Commission of the PRC report in 2015, around 533 out
of 100,000 people died from chronic disease in 2012 in China,
accounting for 86.6% of all deaths.
Nanostructured
Drug Market – Regional Landscape
The key players
operating in the global nanostructured drug market include
Nanoviricides Inc., Ablynx NV, Pfizer Inc., Nanotherapeutics Inc.,
Arrowhead Research Inc., Abraxis Inc., Merck, Bio-Gate AG, and
Celgene Corporation. Market players are focused on adopting of
strategies such as increasing funding, acquisition, and collaboration
to strengthen their product portfolio and to hold dominant position
in the market, For instance, in 2016, Pfizer Inc. received
bankruptcy-court approval to buy all asserts of Bind Therapeutics a
biotechnology company developing targeted and programmable
therapeutics (nanomedicine) called ACCURINS.
Nanostructured
Drug Market Taxonomy
On the basis of
technology, the global nanostructured drug market is segmented into:
Nanoparticles
Nanocrystals
Nanotubes
Liposomes
Micelles
Others
On the basis of
application, the global nanostructured drug market is segmented into:
Neurology
Oncology
Cardiovascular/Physiology
Anti-inflammatory/Immunology
Anti-infective
Others
On the basis of
geography, the global nanostructured drug market is segmented into:
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment